| 951 |
NORFLOXACIN |
NORFLOXACIN 400 MG |
TABLET |
BLISTERPACK |
INFECTIONS CAUSED BY SENSITIVE PATHOGENS : GONORRHEA, PNEUMONIA |
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
01 L 0675/16 |
11-SEP-2023 |
10-SEP-2026 |
View |
| 952 |
NOTALGIN |
METAMIZOL 1G/2 ML |
INJECTION |
AMPOULES |
ANTI-INFLAMMATORY |
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
03 L 0050/92 |
29-AUG-2023 |
28-AUG-2026 |
View |
| 953 |
NSS |
SODIUM CHLORIDE 0.9% |
INFUSION |
Sachet |
TREATMENT OF BLOOD OSMOTIC, USE FOR SLINE DIURETIC |
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
01 L 0003/92 |
24-SEP-2024 |
23-SEP-2027 |
View |
| 954 |
OFLOXACINE |
OfLOXACIN 30MG, Distilled Water q.s.to 10 ml |
EAR DROPS
|
BOTTLE
|
|
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
12 L 0814/19 |
31-JUL-2023 |
30-JUL-2026 |
View |
| 955 |
OFLOXIN |
OFLOXACIN 200MG |
TABLET |
blisterpac |
FOR INFECTION OF RESPIRATORY TRACT, GENITAL-URINARY TRACT, GASTRO-INTESTINAL TRACT, SKIN AND SOFT TISSUES.… |
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 0378/00 |
14-NOV-2022 |
13-NOV-2025 |
View |
| 956 |
OPTO - TIFO |
CHLORAMPHENICOL 0.5%/10 ML |
Eye drops |
bottle |
|
NULL |
FACTORY NO.2 |
FACTORY No.2 |
LAO PDR |
CERTIFICATE RELEASED |
12 L 0798/19 |
31-JUL-2023 |
30-JUL-2026 |
View |
| 957 |
ORAL |
GLUCOSE ANHYDROUS 20G + SODIUM CHLORIDE 1.5G + TRISODIUM CITRATE DIHYDRATE 2.9G+POTASSIUM CHLORIDE 1.5G+CITRIC ACIDE Q.S. |
POWDER |
Sachet |
REHYDRATATION ORAL |
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
06 L 0298/98 |
20-JUN-2023 |
19-JUN-2026 |
View |
| 958 |
ORAL |
DEXTROSE ANHYDROUS 20G + SODIUM CHLORIDE 3.5G + SODIUM CITRATE 2.9G + POTASSIUM CHLORIDE 1.5G |
POWDER |
Sachet |
FLUID AND ELECTROLYTE LOSS IN DIARRHOEA |
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
08 L 0132/95 |
11-DEC-2024 |
10-DEC-2029 |
View |
| 959 |
OSELTAMAKS |
OSELTAMIVIR 75 MG |
CAPSULE |
BOTTLE |
TREATMENT OF ACUTE, UNCOMPLICATED ILLNESS DUE TO INFLUENZA A AND B INFECTION IN PATIENTS 2 WEEKS OF AGE AND OLDER WHO HAVE BEEN SYMPTOMATIC FOR NO MORE THAN 48 HOURS |
NULL |
FACTORY NO.2 |
FACTORY NO. 2 |
LAO PDR |
CERTIFICATE RELEASED |
11 L 1265/24 |
11-DEC-2024 |
10-DEC-2029 |
View |
| 960 |
OSIMAKS 80 |
OSIMERTINIB 80 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF PATIENTS WITH METASTATIC EPIDERMAL GROWTH FACTOR RECEPTOR T790M MUTATION NON SMALL CELL LUNG CANCER. |
NULL |
FACTORY NO.2 |
FACTORY No.2 |
LAOS |
CERTIFICATE RELEASED |
12 L 1046/23 |
15-Dec-2023 |
14-Dec-2026 |
View |
